AKT1 and breast cancer: Previous studies indicate that dysregulation of the PI3K/Akt/mTOR pathway plays an essential role in the tumorigenesis of BC and targeting the PI3K/Akt/mTOR pathway is a potential therapeutic strategy for BC.